Skip to main content

Want a detailed portfolio tracker?

Vanda Pharmaceuticals (VNDA) P/E (2010 - 2026)

Vanda Pharmaceuticals (VNDA) P/E from Jun 30, 2010 to Jul 20, 2026. The TTM Vanda Pharmaceuticals (VNDA) P/E is -1.32. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Vanda Pharmaceuticals (VNDA)

YearP/EChange
2026-1.32-44.27%
2025-2.36-84.00%
2024-14.77-172.19%
202320.46-67.87%
202263.68+141.60%
202126.36-14.44%
202030.80+306.71%
20197.57-86.05%
201854.30-214.52%
2017-47.42+122.65%
2016-21.30+114.73%
2015-9.92-115.13%
201465.55-453.83%
2013-18.53+407.59%
2012-3.65-97.38%
2011-139.23-342.97%
201057.30N/A

Comparison Vanda Pharmaceuticals (VNDA) P/E with competitors

Vanda Pharmaceuticals (VNDA) P/E is -1.32.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.13%
NBYStablecoin Development Corp0.00-100.33%
ENLVEnlivex Ltd0.07-105.68%
FGENFibroGen Inc0.24-118.23%
CHRSCoherus Biosciences Inc0.85-164.43%
FBIOFortress Biotech Inc0.95-172.06%
ORMPOramed Pharmaceuticals Inc1.50-214.12%
AGENAgenus Inc3.01-328.51%
INVAInnoviva Inc3.15-339.47%
VXRTVaxart Inc3.55-369.52%
CRMDCorMedix Inc3.63-375.49%
CVACCureVac N.V.4.45-437.54%
GLPGGalapagos NV4.86-468.92%
SRPTSarepta Therapeutics Inc4.88-470.68%
ABEOAbeona Therapeutics Inc5.39-509.05%
ABUSArbutus Biopharma Corp5.60-524.85%
ZVRAZevra Therapeutics Inc5.89-547.00%
SPROSpero Therapeutics Inc6.23-572.90%
CGENCompugen Ltd6.31-579.39%
RIGLRigel Pharmaceuticals6.87-621.77%
SLXNSilexion Therapeutics Corp7.30-653.96%
OMEROmeros Corporation9.26-802.98%
AUPHAurinia Pharmaceuticals Inc9.58-827.75%
PLXProtalix BioTherapeutics Inc10.89-926.92%
ACADAcadia Pharmaceuticals Inc11.73-990.51%
TBPHTheravance Biopharma Inc12.26-1031.02%
ADMAAdma Biologics Inc12.42-1042.87%
HRMYHarmony Biosciences Holdings Inc13.82-1149.32%
SABSSAB Biotherapeutics Inc14.14-1173.31%
NAGENiagen Bioscience Inc14.82-1225.09%
INCYIncyte Corp15.82-1301.35%
REGNRegeneron Pharmaceuticals Inc15.86-1303.94%
PBYIPuma Biotechnology Inc17.32-1414.72%
CPRXCatalyst Pharmaceuticals Inc17.44-1424.11%
EXELExelixis Inc17.54-1431.60%
TGTXTG Therapeutics Inc18.97-1540.03%
MDXGMimedx Group Inc20.55-1660.48%
XOMAXOMA Royalty Corp22.87-1836.84%
ARGXArgen X SE24.30-1944.91%
CTMXCytomX Therapeutics Inc24.82-1984.63%
XOMAOXOMA Royalty Corp25.34-2024.40%
HALOHalozyme Therapeutics Inc25.62-2045.57%
XOMAPXOMA Royalty Corp25.67-2049.10%
VRTXVertex Pharmaceuticals Inc27.99-2225.60%
RPRXRoyalty Pharma plc - Class A28.69-2278.21%
SLNOSoleno Therapeutics Inc29.02-2303.09%
ASNDAscendis Pharma A/S30.09-2384.35%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2978.61%
APLSApellis Pharmaceuticals Inc39.02-3062.83%
BMRNBiomarin Pharmaceutical Inc42.21-3305.09%
KRYSKrystal Biotech Inc45.34-3542.87%
ONCBeiGene Ltd69.54-5380.11%
PHARPharming Group N.V.75.03-5796.59%
TECHBio-Techne Corp101.96-7841.56%
VCELVericel Corp109.92-8446.18%
ALNYAlnylam Pharmaceuticals Inc117.96-9056.93%
GMABGenmab140.29-10752.09%
TLXTelix Pharmaceuticals Ltd162.15-12412.05%
CORTCorcept Therapeutics Inc212.86-16261.99%